From: Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries
Studies pooled
Treatment
PEa
95 % CI lower limit
95 % CI upper limit
030 and 045
Placebo
Tafenoquine 200-mg weekly
94.1
89.7
96.6
030, 043 and 045
93.4
89.6
95.8